Welcome back 🤩
Actors aged from four to over 50 will take to the stage in the first full company production for a theatre since Covid.
Corey Scott is in the adult cast. He said: “Rehearsing has been like escaping the world because you express your creative flair. I am looking forward to being on stage and seeing the audience reaction. I think they will cheer, scream, boo and laugh.” In every group there are members with additional needs, some hidden, some visible, but every member has an important part to play.
Pantomimes are often seen as a Christmas or New Year production, but Kelsea said: “We do things differently here, so we will be putting on a panto that goes wrong – at Easter. It has been led by the company and we have taken the script and shortened it to about 45 minutes.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Hamilton ticket prices confirmed at Manchester Palace Theatre with some at £13Hamilton ticket prices confirmed at Manchester Palace Theatre with some as cheap as £13
Read more »
Frontiers | A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 BetaLicensed COVID-19 vaccines ameliorate viral infection by inducing production of neutralizing antibodies that bind the SARS-CoV-2 Spike protein and inhibit viral cellular entry. However, the clinical effectiveness of these vaccines is transitory as viral variants escape antibody neutralization. Effective vaccines that solely rely upon a T cell response to combat SARS-CoV-2 infection could be transformational because they can utilize highly conserved short pan-variant peptide epitopes, but a mRNA-LNP T cell vaccine has not been shown to provide effective anti-SARS-CoV-2 prophylaxis. Here we show a mRNA-LNP vaccine (MIT-T-COVID) based on highly conserved short peptide epitopes activates CD8+ and CD4+ T cell responses that attenuate morbidity and prevent mortality in HLA-A*02:01 transgenic mice infected with SARS-CoV-2 Beta (B.1.351). We found CD8+ T cells in mice immunized with MIT-T-COVID vaccine significantly increased from 1.1% to 24.0% of total pulmonary nucleated cells prior to and at 7 days post infection (dpi), respectively, indicating dynamic recruitment of circulating specific T cells into the infected lungs. Mice immunized with MIT-T-COVID had 2.8 (2 dpi) and 3.3 (7 dpi) times more lung infiltrating CD8+ T cells than unimmunized mice. Mice immunized with MIT-T-COVID had 17.4 times more lung infiltrating CD4+ T cells than unimmunized mice (7 dpi). The undetectable specific antibody response in MIT-T-COVID-immunized mice demonstrates specific T cell responses alone can effectively attenuate the pathogenesis of SARS-CoV-2 infection. Our results suggest further study is merited for pan-variant T cell vaccines, including for individuals that cannot produce neutralizing antibodies or to help mitigate Long COVID.
Read more »
Exploring COVID-19 immunization speed and timing in AfricaA new BMC Medicine study retrospectively analyzed the impact of COVID-19 vaccination timing and speed on the virus transmission in 27 African countries, based on a combined epidemiological and economic modeling approach. The authors aimed to inform future decisions about vaccine roll-out and investment.
Read more »
COVID-19 vaccination may reduce the risk of thrombosis in hospitalized patientsA study published in the British Journal of Hematology describes that coronavirus disease 2019 (COVID-19) vaccines are effective in reducing thrombotic events and preventing disease severity in individuals with breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Read more »